Dehoratius, Raphael J.
Brent, Lawrence H.
Curtis, Jeffrey R.
Ellis, Lorie A
Tang, Kezhen L.
Funding for this research was provided by:
Janssen Research and Development
Article History
First Online: 9 February 2018
Compliance with Ethical Standards
: The GO-SAVE trial (NCT01004432, EudraCT 2009-010582-23) was conducted according to the principles of the Declaration of Helsinki and International Committee on Harmonisation good clinical practices. The protocol was approved by each study site’s governing ethical body, and patients provided written informed consent prior to the conduct of any study-related procedures.
: Dr. Brent owns Johnson & Johnson stock. Dr. Curtis has received funding for research, fees for consulting and/or honoraria from AbbVie, Amgen, BMS, CORRONA, Crescendo Bioscience, Janssen, Lilly, Myriad, Pfizer, Roche/Genentech, and UCB. Dr. Ellis is an employee of Janssen. Dr. Ellis owns stock in Johnson & Johnson. Drs. Dehoratius and Tang were employed by Janssen at the time of manuscript preparation.